Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 815.8 INR -1.94% Market Closed
Market Cap: ₹146.1B

Profitability Summary

Natco Pharma Ltd's profitability score is 70/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

70/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

70/100
Profitability
Score
70/100
Profitability
Score

Margins

Earnings Waterfall
Natco Pharma Ltd

Margins Comparison
Natco Pharma Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Natco Pharma Ltd
NSE:NATCOPHARM
146B INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
538.2B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
279.1B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
214.8B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
267.5B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
149.5B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
97.4B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Natco Pharma Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Natco Pharma Ltd
NSE:NATCOPHARM
146B INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
538.2B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
279.1B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
214.8B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
267.5B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
149.5B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
97.4B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Natco Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate